NASDAQ$SAIC

Science Applications International Corporation · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

SAIC's revenue and earnings per share increased, driven by organic growth and record profitability.

SAIC announced its Q2 Fiscal Year 2022 results, with revenues increasing to $1.8 billion and diluted earnings per share increasing to $1.41. The company also raised its revenue, adjusted EBITDA margin, and adjusted diluted EPS guidance for fiscal year 2022.

  • Revenues increased to $1.8 billion, a 4.1% total revenue growth.
  • Diluted earnings per share increased to $1.41; Adjusted diluted earnings per share increased to $1.97.
  • Net bookings of $1.6 billion; Book-to-bill ratio of 0.9 for the second quarter.
  • Company raises revenue, adjusted EBITDA margin and adjusted diluted EPS guidance for fiscal year 2022.

Headline financials

Total Revenue

$1.84B

Previous: $1.76B+4.1%
EPS (adj)

$1.97

Previous: $1.63+20.9%
Total backlog

$24B

Previous: $19.4B+23.7%
Capital Expenditures

-$17M

Previous: -$23M+26.1%
Free Cash Flow

$65M

Previous: $28M+132.1%
Net Income

$82M

Previous: $51M+60.8%
Operating Income

$133M

Previous: $100M+33.0%
Gross Profit

$232M

Previous: $200M+16.0%
Cash & Equivalents

$133M

Previous: $197M-32.5%
Total Assets

$5.91B

Previous: $5.95B-0.7%
Stock-Based Comp

$14M

Previous: $10M+40.0%

Revenue & EPS history

SAIC · Revenue · Quarterly

$1.84B

Q2 2022+4.1%vs Q2 2021
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Forward guidance

The Company is updating previously provided fiscal year 2022 guidance. The guidance assumes expected negative COVID-19 impact of approximately $125 million in revenue and approximately $10 million in adjusted EBITDA. The guidance also assumes that support currently provided under Section 3610 of the CARES Act continues through the end of fiscal year 2022 (January 28, 2022).

Tailwinds

  • Revenue: $7.30 billion - $7.40 billion
  • Adjusted EBITDA Margin: 8.9% to 9.0%
  • Adjusted Diluted EPS: $6.50 - $6.70
  • Free Cash Flow: $430 million to $470 million
  • Assumes support currently provided under Section 3610 of the CARES Act continues through the end of fiscal year 2022 (January 28, 2022).

Headwinds

  • Assumes expected negative COVID-19 impact of approximately $125 million in revenue
  • Assumes expected negative COVID-19 impact of approximately $10 million in adjusted EBITDA
  • Estimates of future revenues are subject to risks, uncertainties and assumptions.
  • Estimates of operating income are subject to risks, uncertainties and assumptions.
  • Estimates of earnings per share are subject to risks, uncertainties and assumptions.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

+0.2%

Avg return

Earnings day

-1.2%

Avg return

5 days after

-0.1%

Avg return

30 days after

54%

31 / 57 earnings

Positive

+16.4%

Q3 2026

Best reaction

-18.4%

Q2 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+1.2%+5.3%+4.7%
Q3 2026+16.4%+11.2%+15.6%
Q2 2026-6.8%-9.9%-10.9%
Q1 2026-13.2%-8.8%+1.7%
Q4 2025+7.2%+1.4%+11.4%
Q3 2025-4.7%-6.4%-7.9%
Q2 2025+3.0%+4.4%+12.7%
Q1 2025-12.9%-14.1%-13.6%
Q4 2024-11.2%-11.3%-12.6%
Q3 2024+9.9%+6.5%+2.9%
Q2 2024-4.5%-3.7%-7.7%
Q1 2024+1.7%+4.2%+11.6%
Q4 2023-0.0%+0.4%-7.0%
Q3 2023+5.4%+1.1%-0.4%
Q2 2023+0.9%+1.0%-2.9%
Q1 2023+7.5%+2.1%+6.7%
Q4 2022-0.7%+1.2%-6.7%
Q3 2022-1.0%-3.3%+1.4%
Q2 2022+3.6%+1.1%+2.2%
Q1 2022+2.5%+0.8%-4.7%
Q4 2021-15.6%-12.0%-7.9%
Q3 2021+3.9%+3.5%+0.5%
Q2 2021+0.5%-0.8%-4.3%
Q1 2021-3.2%-2.2%-14.4%
Q4 2020+6.6%+10.9%+26.6%
Q3 2020+0.5%-1.5%+4.5%
Q2 2020-7.1%-9.0%-5.5%
Q1 2020+8.5%+7.1%+11.0%
Q4 2019+5.0%+3.8%+1.0%
Q3 2019+7.1%+6.7%-1.3%
Q2 2019-10.6%-11.5%-18.6%
Q1 2019-8.5%-9.0%-3.3%
Q4 2018+9.3%+12.9%+17.6%
Q3 2018+9.4%+5.7%+6.7%
Q2 2018-18.4%-16.9%-7.3%
Q1 2018-3.3%-7.9%-6.1%
Q4 2017-13.7%-14.4%-15.4%
Q3 2017+8.0%+3.4%+4.2%
Q2 2017+1.8%+1.8%+4.6%
Q1 2017+1.2%-2.1%+4.6%
Q4 2016+12.3%
Q3 2016-0.9%
Q2 2016-12.3%
Q1 2016-4.5%
Q4 2015-6.2%
Q3 2015+2.5%
Q2 2015+1.7%
Q1 2014+12.1%
Q1 2015+12.1%
Q4 2012+7.8%
Q1 2013+7.8%
Q4 2014+10.2%
Q3 2013-7.9%
Q3 2014-5.4%
Q4 2013-0.4%
Q2 2014-0.4%
Q2 2013-0.4%
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2010

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro